Emergent Health Corp
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EMGE research report →
About the company
Emergent Health Corp. focuses on the creation and distribution of advanced regenerative medicine, alongside a variety of nutraceuticals and plant-derived nutritional supplements. The company's product portfolio features Vita-Stim, a potent nutrient formulated to strengthen the immune system, promote stem cell vitality, and support general well-being.
- CEO
- James W. Zimbler
- IPO
- 2009
- Employees
- 6
- HQ
- King of Prussia, PA, US
Price Chart
- Market Cap
- $4.19K
- P/E
- -0.03
- P/S
- 0.00
- P/B
- -0.02
- EV/EBITDA
- -1.77
- Div Yield
- 0.00%
- Gross Margin
- 63.49%
- Op Margin
- -86.10%
- Net Margin
- -99.57%
- ROE
- 90.88%
- ROIC
- -1079.22%
- Revenue
- $1.64M · 184.54%
- Net Income
- $-1,628,073 · 22.75%
- EPS
- $-0.00 · 50.62%
- Op Income
- $-1,407,830
- FCF YoY
- 37.32%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -8.39
- Avg Volume
- 31.56K
Get TickerSpark's AI analysis on EMGE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our EMGE coverage
Recent articles, reports, and earnings notes.
No research on EMGE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EMGE report →Similar companies
Peers in the same neighborhood.